公开(公告)号：US20200030395A1

公开(公告)日：2020-01-30

申请号：US16337263

申请日：2017-02-16

Applicant: Dae Hee LEE ,  CNG BIO CO., LTD.

Inventor： Dae Hee LEE ,  Jae Kang LEE

IPC: A61K36/07 ,  A61P1/10 ,  A61P1/12 ,  A61K9/00 ,  A61K35/745 ,  A61K35/747 ,  A23L33/135 ,  A23L33/105 ,  A23L33/125

Abstract: The present invention relates to a probiotics composition containing: lactic acid bacteria powder comprising lactic acid bacteria selected from the group consisting of Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus plantarum, and Lactobacillus rhamnosus; a mushroom extract; and a fructooligosaccharide.

公开(公告)号：US20230365501A1

公开(公告)日：2023-11-16

申请号：US18028110

申请日：2021-09-17

Applicant: CNG BIO CO., LTD. ,  CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION ,  GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Inventor： Jaekyung JUNG ,  Mi Kyeong LEE ,  Dae Hee LEE ,  Jae Kang LEE ,  Sun Yeou KIM ,  Da Hye YOON ,  Seong Min HONG

IPC: C07D209/44 ,  A61P25/28

CPC classification number: C07D209/44 ,  A61P25/28

Abstract: The present invention relates to: a novel 4-methoxy-2-phenethyl isoindolin-1-one derivative compound having the ability to promote the increase of nerve growth factor, the ability to promote the growth of nerve cells, and antineuritic activity; and a composition for preventing, improving and treating neurological diseases, comprising the same.

公开(公告)号：US20230331672A1

公开(公告)日：2023-10-19

申请号：US18028100

申请日：2021-09-17

Applicant: CNG BIO CO., LTD. ,  CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION ,  GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Inventor： Jaekyung JUNG ,  Mi Kyeong LEE ,  Dae Hee LEE ,  Jae Kang LEE ,  Sun Yeou KIM ,  Da Hye YOON ,  Seong Min HONG

IPC: C07D209/46 ,  C07D491/048 ,  A61P25/16 ,  A61P25/28 ,  A23L33/10

CPC classification number: C07D209/46 ,  C07D491/048 ,  A61P25/16 ,  A61P25/28 ,  A23L33/10

Abstract: The present invention relates to: a novel 6-methoxy-2-phenethyl isoindolin-1-one derivative compound having the ability to promote the increase of nerve growth factor, the ability to promote the growth of nerve cells, and antineuritic activity; and a composition for preventing, improving and treating neurological diseases, comprising the same.